Biology & biomedicineA molecular mechanism of the cardiac alternans, one of the causes of severe cardiac arrhythmia, has been identified
- Details
- Category: Projects
-
27 Apr 2021
An international project with participation of IIBB-CSIC has identified one of the molecular mechanisms that causes the so-called “cardiac alternans”, an alteration of the cardiac rhythm that can cause ventricular fibrillation and potentially lethal cardiac arrhythmia. This finding opens a new path to the development of pharmacological treatment.
Bio-nanocellulose meshes improve hernia repair surgery
- Details
- Category: Success stories
-
20 Apr 2021
Researchers from the Institute of Materials Science of Barcelona (ICMAB-CSIC) and B. Braun Surgical, a leading manufacturer of medical devices for wound closure, have collaborated to develop a bio-based surgical mesh with this biomaterial. First results from an in vivo animal study yield promising outcomes.
IBMB-CSIC acquires a state-of-the-art electronic microscope with the most advanced electrons detector
- Details
- Category: Laboratories
-
26 Feb 2021
The microscope has been acquired by means of a cooperative project headed by CSIC, through IBMB, and has been co-financed by European FEDER funds. It is a cutting-edge technology for protein structure resolution, and it will allow facing the new biomedicine and biotechnology challenges.
Multiplexed 'point-of-care' device for a quick simultaneous detection of biomarkers
- Details
- Category: Technological offers
-
17 Mar 2021
CSIC scientists have developed a compact device for a rapid and simultaneous detection of several biomarkers in biological fluids. The design simplifies scalability and reduces production costs, which is especially important for the obtention of ‘point-of-care’ diagnostic devices. Industrial partners from the biomedical industry are being sought to collaborate through a patent licence agreement.
A more effective nanomedicine has been developed for the treatment of Fabry rare disease
- Details
- Category: Success stories
-
26 Feb 2021
This is one of the major achievements of the European Smart4Fabry project, which is now coming to an end after four years of work. The results have been made possible by nanotechnology and the approach developed could be applied to other drugs in the future. The new drug improves on current treatments and helps reduce costs and improve patients' quality of life.
